Noom is grounded in science.
It’s at the heart of everything we do
Evidence-Based Science
We have more than 40 peer-reviewed scientific articles that inform users, practitioners, scientists, and the public about how our methods work and how effective they are, as well as provide more general observational information that contributes to science.
Our team of behavioral health experts have PhDs and masters degrees in psychology, neuroscience, and statistics. We make scientific discoveries about all aspects of behavior change, making the world a healthier place.
Our research spans many different areas of health, including oncology, diabetes prevention, hypertension, diabetes management, and more.
Featured Publications
Peer-Reviewed Scientific Journal Articles
JMIR mHealth.
2020
Mobile Delivery of the Diabetes Prevention Program in People With Prediabetes: Randomized Controlled Trial
Health Education & Behavior.
2021
Men’s Weight Loss Outcomes, Behaviors, and Perceptions in Self-Directed Commercial Mobile Program: Retrospective Analysis
JMIR Formative.
2022
Noom Mood: Feasibility, Acceptability, and Preliminary Outcomes of a CBT-based Mobile Mental Well-being Program
IJERPH.
2022
Executive Function-Related Improvements on a Commercial CBT-Based Weight Management Intervention: Pilot Randomized Controlled Trial
Participate in Research
We’re currently running studies that explore all aspects of behavior change to make the world a healthier place.
Research on Diabetes
The Noom Diabetes Prevention Program (DPP) was the first virtual DPP to receive full CDC recognition.
Have questions?Please email research@noom.com
Scientific Advisory Board
Our scientific advisory board is composed of world-renowned experts in health behavior and outcomes.
Sabine Wilhelm
PROFESSOR, Harvard Medical School
CHIEF OF PSYCHOLOGY, Massachusetts General Hospital Director, Center for Digital Mental Health, MGH; Director, Center for OCD and Related Disorders, MGH
Dr. Wilhelm’s groundbreaking research focuses on using technology to improve mental health. Her expertise lies in obsessive-compulsive and related disorders, cognitive-behavioral therapy, and mental health more broadly. She has published more than 320 peer-reviewed articles, reviews, and chapters. She also served as President of the Association for Behavioral and Cognitive Therapies (ABCT).
Andrew Steptoe
PROFESSORof Psychology and Epidemiology, University College London
HEAD OF THE RESEARCH DEPARTMENTof Behavioral Science and Health, University College London
Dr. Steptoe is a leading expert in health and aging, the psychobiology of health and disease, and health behavior research. He has published over 700 peer-reviewed articles and authored or edited 20 books. He served as the President of the International Society of Behavioral Medicine and is the founding editor of the British Journal of Health Psychology.
David Marrero
PROFESSOR of Public Health and Medicine, University of Arizona
DIRECTOR The University of Arizona Center for Border Health Disparities
Dr. Marrero is a recognized expert in early diabetes intervention, community health programs, and medication adherence. He significantly advanced development of the Diabetes Prevention Program, the gold standard lifestyle intervention for diabetes prevention, as well as the TRIAD study, which examined diabetes treatment in managed-care settings. He served as President for Healthcare and Education for the American Diabetes Association.
Tom Hildebrandt
ASSOCIATE PROFESSOR of Psychiatry, ICAHN School of Medicine at Mount Sinai Hospital.
CHIEF OF THE DIVISION OF EATING & WEIGHT DISORDERS, Mount Sinai.
Dr. Hildebrandt’s extensive expertise lies in eating and weight disorders, as well as obesity more broadly. He has published over 100 peer-reviewed articles and 50 presentations on body image, eating disorders, and obesity, among others. His research uses a variety of methods, such as novel, cutting edge techniques to provide effective interventions to patients across all ages.
Analysis
The Latest Insights
The latest data on how behavior change can improve health, brought to you by Noom’s research scientists.
When we’re not working on scientific publications, we explore interesting data trends and learn fun insights from our users. Want to know how food consumption changed around the latest holiday, or the trending new snacks this year?
Check back often for our latest analyses.
Noom Backs First Obesity Bill of Rights
Jan 31, 2024
Obesity is a growing epidemic in the United States, affecting over 100 million adults, or 42 percent of the population. However, only 10 percent of those individuals receive help from medical professionals. The National Consumers League (NCL) and the National Council...
Noom’s Debut Book: Psychology-Driven Approach
Dec 27, 2022
The digital health platform’s first book, "The Noom Mindset," marks its entrance into the offline market NEW YORK – December 27, 2022 – Noom, the leading psychology-backed behavior change program, today published its first book, “The Noom Mindset: Learn the Science,...
Press Release: Noom Announces Enterprise Offering
Nov 14, 2022
'Noom for Work' brings Noom's award-winning mind and body programs to employers and health plans NEW YORK,Nov. 14, 2022/PRNewswire/ --Noom, a leading digital health platform focused on behavior change, today announced the company's new...
Introducing Enhanced Flexibility & Safety Updates
Aug 15, 2022
Calorie Zones, Food Color-Coding, Nursing Tools and more We continually improve and update Noom for two big reasons: first, we are based in science, and science is always evolving; and second, we constantly seek to implement feedback we hear from our community on how...
Ozempic vs. Trulicity: Which is the best option for weight loss?
Jun 19, 2024
What you’ll learn: Both Ozempic and Trulicity can aid in weight loss by mimicking a natural hormone that curbs appetite. Both medications effectively manage blood sugar and help with weight loss. Ozempic may be more effective for weight loss for some people. You’ve...
Ozempic vs. Mounjaro: Which is the best option for weight loss?
Jun 14, 2024
What you’ll learn: Both Ozempic and Mounjaro are effective for weight loss, with Mounjaro potentially offering greater results. Ozempic and Mounjaro can be prescribed off-label for weight loss, but they are not FDA-approved for it. They work differently: Mounjaro...
Ozempic vs. Saxenda: Which is the best option for weight loss?
Jun 14, 2024
What you’ll learn: Saxenda and Ozempic are both GLP-1 receptor agonists that can help you lose weight, but they are approved for different uses. Ozempic is a weekly injection, while Saxenda is a daily injection. Ozempic might be more effective in some cases. Weight...
SCIENCE SPOTLIGHT
Can sense of smell impact health and weight?
A recent study showed that mice who’ve lost their sense of smell had a faster metabolism, better fat-burning, and lower obesity than mice with normal noses.
What does this mean?
This study was done on mice, so it’s too early to say whether you should start holding your nose while eating lunch. However, it does suggest that smell isn’t just about enjoying your meal, it can also trigger your body to build up fat stores.
Contact Us
Thanks for your interest in Noom.
Please use the form below if you have questions about our research or would like to partner and contribute to our science.
If you’d like to partner with us, please let us know about your research interests and what kind of collaboration you’re envisioning.
"*" indicates required fields